-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the afternoon of July 15th, General Technology Group, General Technology China Medical and Guang'anmen Hospital of China Academy of Chinese Medical Sciences signed a strategic cooperation framework agreement, and the two parties will carry out all-round strategic cooperation in the field of medicine, healthcare, and healthcare
It is reported that in this strategic cooperation, the two parties will jointly build a world-class national TCM oncology center with a significant leading and exemplary role, jointly create a modern and digital R&D and industrialization base for Chinese medicine, and create a dual-brand characteristic service platform, and promote , Technical services, and the internationalization of Chinese medicine.
According to reports, in the next step, General Technology Group, General Technology China Medical and Guang'anmen Hospital of China Academy of Chinese Medical Sciences will jointly build a world-class "National Chinese Medicine (Oncology) Medical Center", focusing on four common cancers, and research and development restricts the development of Chinese medicine oncology.
The General Technology Group is a state-owned medical group with a leading number of beds, complete network coverage, and obvious characteristics of the entire industry chain.
China Pharmaceuticals is a specialized operation platform for the pharmaceutical and medical device industries of General Technology Group.